Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

0
82

Funding Opportunity ID: 318538
Opportunity Number: PAS-19-316
Opportunity Title: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.866
Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for eligibility details
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Jul 18, 2019
Close Date: Sep 06, 2022
Last Updated Date: Jul 18, 2019
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding:
Expected Number of Awards:
Description: This Funding Opportunity Announcement (FOA) invites applications to NIA's Small Business Innovation Research (SBIR) program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients.
Version: 1





Visit the Official Webpage For More Details on Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)